Revalidation may perform voluntarily

A drug maker will be allowed to conduct revalidation voluntarily over sterile or non-sterile medicinal products, once the overall manufacturing method or facility/equipment was already validated, according to the Korea Food and Drug Administration.

The current regulation requires that prospective or concurrent validation programs should be established on non-sterile products every five years...